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ABSTRACT: We report a switchable redox click and cleave
reaction strategy for conjugating and releasing a range of
molecules on demand. This chemoselective redox-responsive
ligation (CRRL) and release strategy is based on a redox
switchable oxime linkage that is controlled by mild chemical or
electrochemical redox signals and can be performed at
physiological conditions without the use of a catalyst. Both
conjugation and release reactions are kinetically well behaved
and quantitative. The CRRL strategy is synthetically modular
and easily monitored and characterized by routine analytical
techniques. We demonstrate how the CRRL strategy can be
used for the dynamic generation of cyclic peptides and the
ligation of two different peptides that are stable but can be
selectively cleaved upon changes in the redox environment. We also demonstrate a new redox based delivery of cargoes to live
cells strategy via the CRRL methodology by synthesizing a FRET redox-responsive probe that is selectively activated within a
cellular environment. We believe the ease of the CRRL strategy should find wide use in a range of applications in biology, tissue
engineering, nanoscience, synthetic chemistry, and material science and will expand the suite of current conjugation and release
strategies.
■ INTRODUCTION
The ability to chemoselectively ligate a range of biomolecules,
polymers, nanoparticles, and nanomaterials is fundamental to
current chemistry research and is crucial for a wide range of
applications from protein conjugation, pharmaceutical thera-
pies, molecular electronics, polymer synthesis, drug delivery,
and tissue engineering.1 The most used methods rely on click
chemistry type reactions that span Diels−Alder, Michael
additions, thiol−ene reactions, Staudinger reactions, nucleo-
philic ring-opening reactions, 1,3-dipolar cycloaddition, oxime/
hydrazone formation reactions, and native chemical ligations.2
Although several conjugation methods exist and have been used
for many applications, the use of these methods for in vitro/in
vivo biological studies and applications has been severely
limited due to the special nature of the biological environment
that limits the scope of reactions that may be employed.3 This
subset of conjugation reactions for in vitro/in vivo studies and
applications ideally, at physiological conditions, require kineti-
cally well-behaved reactions that are bio-orthogonal, stable
(covalent bonds), and modular to conjugate a diverse range of
molecules and noncytotoxic compounds. Moreover, a con-
jugation strategy that can be (1) monitored and characterized
with simple nonintrusive analytical methods, and (2) turned on
or off for conjugation, and can (3) release molecules and be
inexpensive would complement and expand the scope of
existing conjugation/release methods for a range of new
applications.
It is well known that aminooxy groups (R-ONH2) selectively
react with carbonyl groups to form stable oxime products,
which have been used as a popular bioconjugation method-
ology for the preparation of ligand microarrays and cell
arrays,4−6 therapeutics, 7 fluorescent labeling, 8 combinatorial
libraries, 9 artificial proteins, 10 glycoprotein mimetics,11
chemically tunable polymers,12 and biosensors.13 Oxime
formation is chemoselective and stable at physiological
conditions.14−16 There are many types of oximes reported
and characterized, and each have unique characteristics
including the quinone oxime; having an oxime moiety
(R1R2CN-O-R3) directly adjacent to the aromatic ring.17
Among them, the quinone oxime ether (QO) and ester have
been studied in the field of stereoelectronic control in organic
chemistry18 and applied to cytotoxin molecules,19 therapeu-
tics,20 and photoinduced iminyl radical generation.21 We have
extensively studied and employed the quinone oxime ether
(QO) as a quantitative immobilization strategy on gold and
indium tin oxide (ITO) surfaces for a range of biotechnological
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and cell behavior studies.22−29 However, until now, the QO
with its interesting aromatic structure and redox properties has
not been explored as a solution based conjugation or cleavage
strategy.
The ability to cleave specific chemical linkages with mild
stimuli is a powerful tool in designing small molecule drugs, in
vivo biosensors, drug delivery methods, solid phase synthesis,
and protein−protein interactions.30−32 There are several
popular classes of cleavable linkers for these applications:
cleavage by reduction (sulfhydryl and diazobenzene), oxidation
(periodate), nucleophilic substitution, and base labile sul-
fones.33 Among them, reduction induced cleavage is attractive
due to its relatively mild induction which can be performed at
physiological conditions. For example, N-succinimidyl 3-(2-
pyridyldithio)-propionate (SPDP) and succinimidyl oxycarbon-
yl-α-methyl-α-(2-pyridyldithio)-toluene (SMPT) are often used
for the preparation of immunotoxin conjugates that contain a
monoclonal antibody which is cross-linked to a protein toxin
molecules, the antibody directed against tumor-associated
antigens. Lambert et al. showed that a disulfide linkage between
the antibody and toxin molecules results in a potent toxicity
when compared to that of noncleavable linkages.34
In this article, we develop a general methodology termed
chemoselective redox-responsive ligation (CRRL) and release
strategy for molecular conjugation and cleavage of a range of
molecules in solution. This methodology relies on the redox
controlled activation, conjugation, release, and regeneration of a
series of electroactive hydroquinone derived molecules. The
strategy is based on the reaction of aminooxy-tethered ligands
with a redox controlled benzoquionone group for subsequent
oxime formation and release. We believe, this CRRL strategy is
dynamic, switchable, kinetically well behaved, stable, inex-
pensive, synthetically flexible, and can be regenerated for
subsequent rounds of conjugation and release. Furthermore,
the CRRL reactions can be monitored by simple UV−vis
spectroscopy methods and controlled by electrochemistry
(either chemical redox reagents or applied potentials). We
characterize the CRRL chemical sequence and then demon-
strate the utility of the CRRL strategy in two ways: (1) by
generating dynamic peptides for cell inhibition assays and (2)
as a redox based system to deliver cargoes specifically to the
interior of cells.
■ MATERIALS AND METHODS
Spectroscopy. Spectra were obtained using a diode-array
spectrophotometer for both standard and kinetics measure-
ments. All of the measurements were performed using quartz
spectrophotometer cells in Dulbecco’s PBS (used as received)
at room temperature. All measurements were initiated
immediately after sample preparation.
Chromatography and Mass Spectrometry. Analytical
HPLC was performed on a diode array detector and an
automated sampler. The samples were eluted through an
Atlantis analytical column (C18, 5 μm, 6 × 150 mm) with a
binary solvent system (solvent A, optima grade water with 5%
optima grade acetonitrile and 0.1% TFA; solvent B, acetonitrile
with 5% water and 0.1% TFA) with a gradient of 0−100%
solvent B over 50 min (1 mL/min). For the LC-MS data for
intra-CRRL RGD (6) and inter-CRRL RGD (9) peptides,
samples were run on a UPLC system coupled to a mass
spectrometer (scanning 300−1600 m/z) using a UPLC column
(BEH C18 1.7 μm, 2.1 × 150 mm, 30 °C). The elution
occurred in a gradient of binary solvents (solvent A, optima
grade water with 0.2% formic acid; solvent B, Optima grade
acetonitrile with 0.2% formic acid), where solvent B increased
from 1% to 40% over 20 min.
CRRL Activation, Conjugation, Release, and Regener-
ation. Activation: the hydroquinone (HQ) can be oxidized to
the benzoquinone (BQ) via chemical or electrochemical
methods. Addition of Cu2+ (2 equivalents) in pH 7.4 PBS
instantly oxidizes HQ to BQ quantitatively. The HQ can also
be oxidized to BQ in solution via electrochemical methods
(potentiostat) by application of an oxidative potential (+750
mV, 1 min, versus a Ag/AgCl reference electrode) to a stirring
solution of HQ (0.1 mM, pH 7.4, PBS) in an electrochemical
cell containing a gold working electrode. Conjugation: the
benzoquinone (BQ) can form a stable quinone oxime ether
(QO) when reacted with aminooxy-containing ligands (R-
ONH2) in a range of pH conditions (pH 1.0 to 10). Release:
the quinone oxime ether (QO) can be chemically or
electrochemically cleaved to release the aminooxy ligand (R-
ONH2) as a primary alcohol (R-OH) with the generation of
aminophenol (AP). Addition of either a soluble reducing agent
(DTT, 5 mM, pH 7.4, PBS, 10 h) or electrochemical reduction
(−100 mV, 1 min, pH 7.4, PBS) causes the efficient cleavage of
QO to AP with high yield (>95%). Regeneration: the
aminophenol (AP) can be oxidized to the quinoneimine,
which rapidly hydrolyzes to generate the benzoquinone (BQ)
with the release of ammonia. The BQ is then reduced to
generate the HQ via a classic electrode chemical (EC)
process.35
Fibroblast (Fb) Culture. Swiss 3T3 albino mouse
fibroblasts were cultured in Dulbecco’s modified Eagle’s
medium (Gibco) containing 10% calf bovine serum (CBS)
and 1% penicillin/streptomycin at 37 °C in 5% CO2.
Cell Adhesion Inhibition Assay. 3T3 Swiss Albino mouse
fibroblasts were pretreated with peptides (6−11) at varying
concentrations and seeded onto a RGD-presenting SAM gold
substrate. We have previously reported and described these
types of surfaces for a range of cell behavior studies.23 Briefly,
gold substrates were immersed in a 1 mM ethanolic solution of
alkanethiolates (1:99 HQ/TEG) for 12 h. The hydroquinone-
containing surfaces were oxidized by applying a potential of 750
mV (vs Ag/AgCl) for 15 s in a 1 M solution of HClO4 using a
BAS 100B/W electrochemical analyzer (Bioanalytical Systems,
Inc., West Lafayette, IN). Then, aminooxy acetic acid-Gly-Arg-
Gly-Asp-Ser-amidated was added (10 mM in PBS) for 3 h to
install the peptide onto the surface. The fibroblasts were
cultured in Dulbecco’s modified Eagle’s medium with 10%
bovine calf serum and 1% penicillin/streptomycin (37 °C in a
humidified 5% CO2 atmosphere). In order to plate cells onto
the SAM substrates, cells were removed from the culture flask
with a solution of 0.05% trypsin/0.53 mM EDTA and
resuspended in serum-free culture medium (5,000−10,000
cells/mL). The 0.3 mL of aliquots are treated with peptides in
various concentrations for 5 min and seeded and incubated for
30 min and gently rinsed with PBS. Adhered cells were counted
at random locations on the substrates (n = 129). The ratio (%)
of adhered cells to the nonpretreated cell control experiments
were plotted.
Cell Treatment with Cell-Permeable Redox-Respon-
sive Calcein Dye (CPRRC, 12). Two microliters of 40 mM
CPRRC was added to 4 mL of culture media for a final
concentration of 10 μM. This mixture was added to fibroblasts
in culture for 1 h. The medium was removed, and 4 mL of fresh
Bioconjugate Chemistry Article
dx.doi.org/10.1021/bc400565y | Bioconjugate Chem. 2014, 25, 543−551544
medium was added. After 1 h, the cells were imaged in PBS
with a Nikon TE2000.
Fluorometry. Ten micromolar CPRRC was prepared in 5
mM glutathione at pH 7. To measure the initial fluorescence,
the fluorescence was scanned from 515 to 600 nm with 495 nm
excitation on a Biocore 765 fluorometer. For the recovery
studies, 525 nm was monitored over 3 h every 2 min. After the
recovery was complete, 515 to 600 nm was scanned again.
■ RESULTS AND DISSCUSSION
Figure 1 shows the cartoon scheme and molecular structures of
the solution based CRRL conjugation and release strategy. A
CRRL receptor can be switched between the off state and on
state by mild chemical or electrochemical redox changes. Only
when the CRRL receptor is turned on can it react
chemoselectively with a CRRL ligand to generate a stable
covalent conjugated pair. The covalent ligation product is stable
but can be selectively released by a mild chemical or
electrochemical reductant. The CRRL cleavage reaction
regenerates the receptor group, while the released ligand is
irreversibly altered at the ligation site. Subsequent rounds of
conjugation and cleavage at physiological conditions (pH 7.4
and 37 °C) can be performed. The reaction is bio-orthogonal,
chemoselective, and may be done in complex protein mixtures
and cell culture.22,23
A hydroquinone (HQ) is the off CRRL receptor and can be
converted to the benzoquinone (BQ) (on CRRL receptor) by
mild chemical oxidants or electrochemical oxidation. This
interconversion process is chemically and electrochemically
reversible, which enables switching between the active and
inactive forms for chemoselective conjugation. An aminooxy-
tethered molecule (R-ONH2; the CRRL ligand) can conjugate
selectively to the BQ form generating a covalent and stable
quinone oxime ether (QO) as a ligation product. The QO can
then be reduced by mild chemical reductants or electrochemical
reduction to yield the aminophenol (AP) with release of the
ligand as a hydroxyl-terminated molecule (R-OH). The HQ
can then be regenerated from aminophenol (AP) by
subsequent steps of oxidation, followed by the hydrolysis of
imine to generate BQ with the liberation of ammonia and then
further reduction of BQ to HQ through a classic EC (electrode
and chemical) mechanism.35
To monitor and characterize the kinetics of the stable
intermediate products of the CRRL conjugation and cleavage
strategy, we used standard UV−vis spectroscopy (Figure 2).
Upon oxidation of hydroquinone (HQ), benzoquinone (BQ) is
formed, which can react with aminooxy groups (R-ONH2) to
form the quinone oxime ether (QO). The QO can then be
cleaved to generate the aminophenol (AP) with all species
having diagnostic absorbances (HQ, 288 nm, ε = 2,520
M−1cm−1; BQ, 248 nm, ε = 20,300 M−1cm−1; QO, 320 nm, ε =
18,163 M−1cm−1; AP, 297 nm, ε = 2,150 M−1cm−1; Figure S1,
Supporting Information). Figure 2a, left shows the conjugation
reaction between BQ and methoxyamine (CH3ONH2)
characterized by UV−vis spectroscopy. To the solution of
BQ (PBS, 200 μM), a solution of methoxyamine (PBS, 100
mM) was added immediately after the initial measurement (0
min). The visible isosbestic point demonstrates that BQ and
QO are linearly related by stoichiometry, supporting that the
reaction is coupled by the formation of QO and decay of BQ.
The absorbances at 248 and 320 nm were plotted against
time in an exponential plot (Figure 2b, left). The exponential
graph was fitted to pseudo-first-order reaction kinetics in order
to obtain k′. After solving for a series of k’s from different
reaction conditions with excess methoxyamine, the k′ values
can be plotted against [methoxyamine] (Figure 2c, left) to
obtain the second-order rate constant for CRRL conjugation, k
= 3.41 × 10−2 (±6.5 × 10−4) M−1s−1 (PBS, room temperature).
The same experiments and calculations were performed for
the CRRL cleavage reaction. To a solution of QO (PBS, 200
μM), dithiothreitol (DTT) (PBS, 100 mM) was added (Figure
Figure 1. Cartoon scheme and molecular cycle of the chemoselective
redox-responsive ligation (CRRL) and release strategy. (Top) A
CRRL receptor tethered to molecule 1 can be switched between the
“off” state (complete circle) and “on” state (incomplete circle) by mild
chemical or electrochemical oxidation and reduction. Only when the
receptor is turned “on” can the CRRL ligand (red arrow) react
chemoselectively to form a conjugated molecule pair. The covalent
ligation product is stable but can be selectively released by a mild
chemical or electrochemical reduction. The CRRL cleavage reaction
regenerates the receptor group while the ligand is irreversibly altered.
Conjugation between the receptor and the ligand, as well as the
cleavage reaction, are fast, mild, clean (no need for catalyst), bio-
orthogonal, and chemoselective in physiological conditions (pH of 7.4
and 37 °C) and complex protein mixtures (cell lysates), which are
essential characteristics for biological applications. (Bottom) A
hydroquinone (HQ) is the “off” CRRL receptor and can be converted
to the benzoquinone (BQ) (“on” CRRL receptor) by mild chemical or
electrochemical oxidation. This activation interconversion process is
chemically and electrochemically reversible, which enables switching
between the active and inactive forms for chemoselective conjugation.
An aminooxy-tethered molecule (R-ONH2; the CRRL ligand) can
conjugate selectively to the BQ form generating a covalent and stable
quinone oxime ether (QO) as a ligation product. The QO is reduced
in mild conditions to yield the aminophenol (AP) with release of the
ligand as a hydroxyl-terminated molecule (R−OH). The activation,
conjugation, and release steps all occur at physiological conditions (pH
7.4, 37 °C). The HQ can then be regenerated from AP by a
subsequent oxidation in low pH followed by hydrolysis of the imine
and reduction by a classic electrode−chemical (EC) mechanism.35
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2a, right). Although DTT masks the spectrum that is lower
than 260 nm, the decrease of QO absorbance at 320 nm and
the appearance of AP at 292 nm could be observed. The
absorbance peak is shifted from 297 to 292 nm for AP because
of the high concentration of DTT. For the case of reduction in
low glutathione (GSH) concentration, AP has an absorbance
peak at 297 nm (Figure S2, Supporting Information).
Commercial AP (200 μM) in 10 mM DTT and PBS also
shows the same absorbance shift. The isosbestic point was not
observed for the conversion of QO to AP due to a peak
absorbance overlap. The rate constant for the CRRL cleavage
reaction was determined to be 6.5 × 10−1 (3.0 × 10−2) M−1s−1
(Figure 2c, right). The reaction products from both CRRL
conjugation (QO) and cleavage reactions (AP) were
characterized by NMR and mass spectrometry (Figures S3
and S4, Supporting Information). These UV characterizations
clearly show that the CRRL conjugation and cleavage reactions
are well behaved and clean at pH 7.4. We found that the key
CRRL conjugation product (QO) is stable at room temper-
ature in PBS for several weeks and could be stored for very long
periods (>6 months) at 0 °C (Figure S5, Supporting
Information).
To conjugate a range of biomolecules using the CRRL
strategy, we used standard solid phase peptide synthesis (SPPS)
to generate dynamic peptides containing the hydroquinone
group at various locations (Figure 3). We first synthesized a
protected hydroquinone-tethered Fmoc amino acid (HQAA;
1) that could easily be incorporated into a standard solid phase
peptide synthesizer for site-specific CRRL chemistry (Figure
3a). A tetrahydro-2H-pyran (THP)-protected HQ-tethered
alkyl azide (5) was synthesized and conjugated to an Fmoc-
protected propargyl glycine by 1,3-dipolar cycloaddition. The
HQAA (1) can be incorporated into any position in a peptide
sequence, enabling control of the conjugation site with routine
Fmoc SPPS (Figure 3b). The THP group can then be
deprotected yielding the HQ using the standard trifluoroacetic
acid (TFA) cleavage step for peptide release from a resin with
∼60% yield (0.1 mmol scale; Figure S6, Supporting
Information). CRRL’s compatibility with facile SPPS is an
important feature for generating a range of biomolecules
including carbohydrates, polymers, nucleic acids, proteins, and
small molecule ligands and nanomaterials that contain the
hydroquinone group for a broad range of applications in
material science and biology.
Figure 2. Kinetics of CRRL conjugation between BQ (200 μM) and methoxyamine (100 mM), and cleavage of QO (200 μM) with dithiothreitol
(DTT) (100 mM), determined by UV−vis spectroscopy. (Left) (a) UV−vis spectra showing the conversion from BQ (248 nm) to QO (320 nm)
with a clear isosbestic point. (b) A plot of absorbance maxima versus time for BQ and QO. An exponential increase of QO and decay of BQ are fitted
to pseudo-first-order kinetics to obtain k′ (4.2 × 10−3 s−1). (c) A plot of k′ versus varying [CH3−ONH2] to determine the second-order rate
constant k for the reaction of BQ with CH3ONH2 to generate QO. The rate constant for CRRL conjugation is 3.4 × 10
−2 (±6.5 × 10−4) M−1s−1.
(Right) (a) UV−vis spectra characterization for the cleavage reaction versus time (QO, 320 nm; AP, 292 nm). (b) A plot of QO (200 μM)
absorbance (320 nm) versus time in the presence of the reductant DTT (10 mM) follows a pseudo-first-order exponential decay (k′ = 7.3 × 10−2
s−1). (c) A plot of k′ versus varying [DTT] to determine the second-order rate constant k for the cleavage of QO to generate AP. The CRRL
cleavage rate constant k = 6.5 × 10−1 (±3.0 × 10−2) M−1s−1.
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In order to demonstrate the utility of the CRRL strategy, we
used the well known cell adhesion peptides discovered by
Pierschbather and Ruoslahti as a model system. They reported
the short peptide sequence Gly-Arg-Gly-Asp-Ser (GRGDS)
found in the extracellular matrix protein fibronectin to be a
minimum cell adhesion ligand for integrin receptors on cell
surfaces.36 Although GRGDS alone can result in cell adhesion,
several other peptide sequences including PHSRN (found in
fibronectin within the FIII9 domain) have been shown to have
a synergistic or competitive adhesion effect.37,38 Furthermore, it
has been shown that cyclic-RGD has a higher activity toward
cell binding than linear-RGD (Kd of nanomolar versus
micromolar, respectively) due to the structural similarity
between the cyclic form and the natural RGD loop in the
FIII10 domain.39 We chose to focus on the RGD cell adhesive
peptide to demonstrate the generation of a dynamic
biomolecule using CRRL, which can modulate its biological
activity by inducing structural changes upon sensing different
redox environments. Two proof-of-concept peptides, intra-
CRRL RGD (6) and inter-CRRL RGD (9), were synthesized
to demonstrate the utility of the CRRL methodology (Figure
4).
The intra-CRRL RGD peptide (6) has the HQAA (1) at the
C-terminus and an aminooxy group at the N-terminus (Figure
4a). An added feature of the CRRL strategy is the ease of
incorporation of an aminooxy group into a peptide by using a
commercially available (Boc-aminooxy)acetic acid, a CRRL
ligand, during standard solid phase peptide synthesis. In a
reducing environment (1 mM DTT in PBS), the intra-CRRL
RGD (6) remains in the linear form for more than 4 days (PBS,
25 °C). When molecule 6 (100 μM) encounters oxidative
conditions (10 mM of copper(II) sulfate pentahydrate in PBS),
the HQ is immediately oxidized to the BQ form, which reacts
rapidly with the aminooxy-functionalized N-terminus to
generate a cyclized RGD peptide (7) (Figure 4b). The cyclized
intra-CRRL RGD peptide (7) is stable for weeks in PBS and
room temperature (25 °C). To regenerate the linearized RGD
peptide, the addition of a reductant (10 mM DTT in PBS, 37
°C) to the purified 7 results in instant cleavage of the oxime
bond to generate the AP group and a hydroxyl-functionalized
N-terminus (8) (Figure 4c). As this intra-CRRL peptide has
both a CRRL receptor and a ligand, characterization of each
state of the peptide was determined by mass spectrometry. This
allows for facile monitoring of the chemical changes occurring
during the CRRL cyclization and cleavage steps of each species
(HQ, oxyamine, QO, AP, and the corresponding hydroxyl
terminated group in a single peptide) during the course of the
CRRL conjugation and release steps.
Similarly, inter-CRRL formation and cleavage between RGD
and PHSRN were characterized by mass spectrometry, as
shown in Figure 4 (right). The inter-CRRL RGD peptide (9)
has a HQAA at the N-terminus for the conjugation of an
aminooxy-tethered PREDRVPHSRN peptide. Oxidative con-
ditions (1 mM Cu2+, PBS, 37 °C) immediately yielded the large
hybrid peptide (10) having a molecular mass of 2479.25, which
can then be dissociated by DTT, yielding the corresponding
AP-RGD (11).
UV−vis spectroscopy also confirmed that the HQ-peptides
(9) behave similarly to the parent molecules (without peptides
attached) (Figure S8, Supporting Information). Intra-CRRL
RGD (6, Figure S8a, Supporting Information) and inter-CRRL
RGD (9, Figure S8b, Supporting Information) showed the
same HQ absorption spectra associated with each CRRL step.
The reduced form of the CRRL peptide (HQ-peptide (6, 9))
was dissolved in H2O (100 μM) and oxidized by the addition of
2 equivalents of Cu2+ to generate QO-peptide (7, 10). For the
inter-CRRL peptide, methoxyamine (100 mM, ddH2O) was
added and oxime formation occurred instantly (QO-peptide).
The QO-peptide was converted to the AP-peptide (9, 11) by
treatment with GSH (5 mM) or DTT (100 mM). The reduced
form of the inter-CRRL RGD (HQ-peptide (9)) was dissolved
in H2O and oxidized by the addition of 2 equivalents of Cu
2+ to
generate the oxidized BQ-peptide. When methoxyamine (100
mM, ddH2O) was added, oxime formation occurred instantly
(QO-peptide). The QO-peptide was converted to the AP-
peptide by treatment with DTT (10 mM). Taken together,
these results show that the CRRL strategy can be used to
cyclize molecules, conjugate to other molecules, and release
molecules responding to environmental redox stimuli with real-
time characterization by a noninvasive straightforward UV−vis
absorption spectroscopy technique. This facile characterization
is important not only for identifying species but for also
determining actual amounts of the CRRL species and for
monitoring the kinetics and therefore degree of conjugation.
As further chemical characterization, a selected ion
chromatogram was performed to demonstrate that each intra-
CRRL peptide species behaves similarly to the corresponding
Figure 3. (a) Synthesis of a protected hydroquinone tethered Fmoc
amino acid (HQAA; 1) for use in solid phase peptide synthesis to
generate peptides containing the hydroquinone group for site-specific
CRRL chemistry. (b) Scheme showing how HQAA (1) can be added
to any site within a peptide by applying standard solid phase peptide
synthesis technology. This strategy allows for the CRRL method to be
incorporated into a variety of biomolecules.
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parent molecule without the peptide (Figure 4), in terms of the
elution durations from a C18 column (Figure S7, Supporting
Information).
As a demonstration to show the utility of the inter- and intra-
CRRL-generated peptides (6−11), we performed a standard
competitive inhibition assay for cell adhesion.37,38 This assay
involves the pretreatment of cells suspended in solution with
soluble inhibitors and then seeding the cells to a tailored and
biospecific ligand surface to evaluate the ability of the soluble
inhibitors on cell adhesion (Figure 5).
Figure 4. (Left) Intramolecular CRRL. A peptide (intra-CRRL RGD, (6)) containing the HQAA (1) and a terminal aminooxy group was
synthesized using standard solid phase peptide synthesis. The CRRL strategy was used to generate a cyclic peptide characterized by liquid
chromatography and mass spectrometry. (a) Structure of the intra-CRRL RGD (6) peptide. (b) A mild oxidant Cu2+ was added in order to oxidize
the HQ to BQ followed by rapid intramolecular oxime formation to generate a cyclic peptide (7). (c) A mild reductant DTT was added to the
solution of cyclized RGD peptide (7) to reduce and therefore cleave the oxime bond to generate the linear peptide (8). Mass spectrometry
characterization of each product in the intramolecular CRRL strategy are shown. All of the reactions were performed at physiological conditions
(PBS, pH 7.4, 37.0 °C). (Right) Intermolecular CRRL demonstrating the conjugation of two different peptides. One peptide (inter-CRRL RGD
(9)) contains the HQ group, while the other (PREDRVPHSRN) has an oxyamine group. Each are easily synthesized using standard solid phase
peptide technology. (a) Inter-CRRL RGD (9) peptide in PBS before reaction. (b) A mild oxidant Cu2+ and oxyamine-PREDRVPHSRN were added
to the PBS solution of inter-CRRL RGD (9) peptide to enable rapid intermolecular CRRL conjugation of the two peptides (10) (PBS, 37.0 °C). (c)
The CRRL product peptide (10) was then selectively cleaved upon treatment of the reductant DTT to yield the linear-RGD peptide (11). (Bottom)
Mass spectrometry characterization of each product in the intermolecular CRRL strategy. All of the reactions were performed at physiological
conditions (PBS, pH 7.4, 37.0 °C).
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Each of the peptides was incubated (pretreated) with Swiss
3T3 fibroblasts in solution at varying concentrations, and then
the cells were seeded to self-assembled monolayer (SAM)
surfaces presenting an immobilized linear-RGD peptide.23 It
has been shown previously that these surfaces are ideal for
evaluating small molecules that perturb cell adhesion.25
Without pretreatment with the peptides (6−11), the cells
efficiently attached to the RGD surfaces through integrin
receptors via biospecific interactions.
Figure 5 shows the cell adhesion inhibition assay as a percent
ratio of each peptide with the nonpretreated cells. As expected,
the cyclic intra-CRRL peptide (cyclic RGD, 7) and the inter-
CRRL hybrid peptide that contains RGD and PHSRN ligands
(10) were the best inhibitors for cell adhesion due to their
higher affinity for integrin receptors than molecules 8, 9, and
11, which are linear forms of the lower affinity RGD peptide for
integrin receptors.37,38 Additionally, QO offers an alternative to
disulfide bonds as a cleavable linker between two target
biomolecules. We determined that CRRL cleavage takes 10 h
for reaction completion in the presence of 5 mM glutathione
(GSH) in PBS (Figure S2, Supporting Information).
As a second demonstration, we utilized the CRRL method-
ology to deliver cargoes to cells via an intracellular redox
cleavage (Figure 6). We took advantage of the reducing
environment found within a cell’s cytoplasm to perform a
selective in vivo CRRL cleavage. In order to show this in vivo
application, we first synthesized a FRET redox-responsive
probe molecule (Figure 6A). This cell-permeable redox-
responsive molecule has three components: (1) a calcein dye
that is fluorescent; (2) a redox center/cleavage site based upon
the quinone group; and (3) a dabcyl group that efficiently
quenches fluorescence. The cell-permeable redox-responsive
calcein dye (CPRRC) molecule is initially not fluorescent but
becomes fluorescent upon reductive cleavage and release of the
Figure 5. Cell adhesion inhibition assay for inter- and intra-CRRL
peptides (6−11). Swiss Albino 3T3 fibroblasts were suspended in
serum-free media and incubated with peptides 6−8 (a) and 9−11 (b)
at various concentrations (10 nM to 1 mM for 5 min at 37 °C). The
pretreated cells were then seeded and incubated onto a biospecific cell
adhesive RGD presenting self-assembled monolayer surface.22 The
cells that adhered were counted, and the ratios (%) of adhered cells to
the nonpretreated cell control were tabulated. (a) Cyclic form of intra-
CRRL RGD (cyclic RGD (7) open triangle) shows higher cell
inhibition than the two linear forms of RGD for the intra-CRRL RGD
(6 and 8, circle and square). (b) PHSRN conjugated inter-CRRL RGD
(dual ligand hybrid (10) open triangle) shows higher cell inhibition
activity than the single ligand nonconjugated forms (9 and 11, circle
and square).
Figure 6. CRRL strategy to release cargo in cells via an intracellular
redox trigger. (A) Structure of a cell-permeable redox-responsive
calcein dye (CPRRC). The molecule has three distinct parts. The
calcein dye is capped to allow the highly charged dye to cross the cell
membrane. The quinone redox center is stable but is cleaved upon
encountering the reducing conditions within a cell. The dabcyl group
quenches the calcein fluorescence via FRET until it is released by the
redox center in the cell cytoplasm. (B) A fluorescence intensity vs
wavelength plot for CPRRC before (black line) and after (green line)
exposure to 5 mM glutathione solution for 2 h. (C) A fluorescence
intensity vs time plot for CPRRC dissolved in 5 mM glutathione
solution. Upon release of the dabcyl quencher, the fluorescence
intensity increases. (D) Cartoon describing the delivery and cleavage
of CPRRC. (E) Fluorescent image of cells before CPRRC exposure
(no fluorescence). (F) Image of cells after 1 h of 10 μM CPRRC
exposure shows bright fluorescence indicating that CPRRC is cleaved
within cells in a redox-responsive manner.
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dabcyl quenching group. It is important to note that the CRRL
methodology works for either oxime or hydrazone linkages to
quinone groups.
Many commercially available ligands have oxyamine or
hydrazine tethers, and this provides tremendous synthetic
flexibility for the CRRL methodology when conjugating and
cleaving a variety of ligands in a redox manner. Figure 6B shows
the difference in fluorescence for the CPRRC molecule before
and after (the dabcyl quenching group is redox released)
exposure to cell cytoplasm-reducing conditions (5 mM of
glutathione) for 2 h. Figure 6C shows the CPRRC fluorescence
intensity profile versus time in the presence of 5 mM
glutathione and indicates that the quinone redox center is
cleaved causing the release of the FRET quenching dabcyl
group, which in turn leads to an increase in fluorescence due to
the unquenched calcein dye.
To test whether the CRRL methodology can selectively work
inside cells, we added the CPRRC molecule to cells in culture
(Figure 6D). Untreated cells showed no fluorescence, while
treated cells (10 μM CPRRC in cell culture media, 1 h) showed
bright fluorescence. As a control, a calcein−dabcyl conjugate
that does not contain the redox center showed no fluorescence
in the same conditions for the cell culture experiments (data
not shown). Taken together, these results show that the
CPRRC molecule is efficiently cleaved in the cell cytoplasm
reductive environment. By incorporating a range of molecules
that are tethered through the quinone redox center, many
biomolecules, imaging agents, and nanoparticles may be
selectively released within a cell. Furthermore since the
CRRL methodology is bio-orthogonal, ligations and cleavage
reactions may be performed within cells or complex protein
mixtures. Finally, the in vivo CRRL strategy may also act as a
redox probe to evaluate the cell’s response to changing stimuli,
which may elicit changes in the local redox environment.
■ CONCLUSIONS
In summary, we introduce a chemoselective redox-responsive
ligation and release strategy. The CRRL strategy is a new class
of conjugation chemistry in that it allows chemoselective
conjugation and cleavage that is responsive to specific redox
stimuli. CRRL is based on the ability of a hydroquinone to
oxidize to a benzoquinone for subsequent reaction with
oxyamine-tethered ligands to generate a stable oxime product.
The oxime can then undergo irreversible cleavage in a reductive
environment to generate an aminophenol and a primary
hydroxyl-terminated ligand. The aminophenol is stable and can
be brought back to the original hydroquinone with mild redox
chemistry for subsequent rounds of conjugation and release.
The CRRL strategy can be monitored in real-time by standard
UV−vis absorption spectroscopy and modulated by chemical or
electrochemical methods. A non-natural amino acid containing
the hydroquinone group was synthesized and shown to
incorporate at selective positions within a peptide by using
standard solid phase peptide synthesis. As a demonstration,
intermolecular and intramolecular CRRL strategies were used
to generate dynamic cyclic peptides and two tethered peptides
that could be conjugated and cleaved. This hydroquinone
amino acid can easily be incorporated to generate redox-
responsive peptide and polymers. As a second demonstration, a
FRET redox-responsive probe was synthesized and shown to
undergo selective redox cleavage upon intracellular uptake. This
strategy may provide new ways to deliver and monitor
biomolecules and cellular events based on the redox environ-
ment. The CRRL methodology not only shares all of the
advantages of traditional oxime chemistry (bio-orthogonal,
high-yield, and chemoselective) but also has a dynamic attribute
associated with conjugation and cleavability. CRRL conjugation
and cleavage occurs quantitatively and in physiological
conditions without the need for a traditional catalyst.
Furthermore, the CRRL strategy is synthetically flexible and
can also be used with hydrazine type molecules instead of
aminooxy groups to generate conjugated hydrazones, which
also undergo the CRRL cycle.40 CRRL is a general method-
ology for conjugation and release and will be a useful tool for
scientists and engineers in various fields aiming to design smart
molecules and materials, which alter their biological activities
according to specific changes in their physiological environ-
ments, or for material science applications.41 The CRRL
strategy is inexpensive, dynamic, kinetically well behaved,
synthetically modular, and straightforward to monitor and
control. To our knowledge, the CRRL strategy is the only
single method that is able to chemoselectively ligate molecules
and to then release the molecules under redox control with
regeneration for potential multiple subsequent rounds of
conjugation and release. Future research will explore how the
CRRL strategy may be used to release or conjugate molecules
to generate dynamic/smart polymers for material science,
nanoscience, and tissue engineering applications. For more
biological applications, dynamic carbohydrates and mixed
CRRL biomolecules (peptides, nucleic acid, and lipids) may
be synthesized and selectively released in vitro and in vivo for a
range of diagnostic/imaging or direct delivery of therapeu-
tics.42−44 We believe, the ease of the CRRL strategy should find
wide use in a range of applications in biology, tissue
engineering, nanoscience, and material science and will expand
the suite of current conjugation and release strategies.
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